Australia between Pfizer and Novavax, what

 1-11-22       The Novavax vaccine has entered final review stages by the Advisory Committee on Vaccines and the Therapeutic Goods Administration in Australia. Australia’s promised supplies of 51m doses of the Novavax vaccine, which failed to arrive in 2021 as planned, may be approved within months after the company finally completed its approval applications with the health department.
        After providing initial data to the Therapeutic Goods Administration in January 2021, the company provided the government with its “complete submission of data and responses” last week.
  The Advisory Committee on Vaccines (ACV), which advises the TGA and the health minister, met to review the Novavax vaccine on Friday. The TGA is now preparing to review the committee’s final report.
    “Once the ACV’s final report is received and reviewed by relevant parties, the TGA will be in a position to make a decision,” a spokesperson for the Department of Health said.
  “The Novavax vaccine candidate will not be rolled out to the Australian public until the TGA has completed a full and thorough assessment.  No part of this process has been rushed, and the TGA will not approve a vaccine unless it is found to be safe and effective” (for big pharma  -r).
        The department noted that the supply of Novavax vaccine after approval would still be dependent on products arriving in Australia and meeting laboratory batch release requirements, noting problems faced by the company last year.  https://www.theguardian.com/australia-news/2022/jan/12/novavax-vaccine-may-be-approved-for-australia-within-months  ……………………........................................
        After Australia finds out that their choice of Novavax and Pfizer may not necessarily work wonders like ivermectin and the other simple treatments…  en.wikipedia.org › wiki › NovavaxNovavax - Wikipedia

Novavax is funded by a mix of private and public investment. In 2015, Novavax received a US$89 million research grant from the Bill and Melinda Gates Foundation to support the development of a vaccine against human respiratory syncytial virus for infants via maternal immunization

. 
…………..................................................................................................

January 13, 2022 - Lance D Johnson            

Pfizer CEO (shown) just admitted his company’s shots are useless, double jabbed have “very limited protection, if any” – so why are governments still paying for Pfizer shots and mandating them?
It took less than a year for Pfizer CEO Albert Bourla to come clean about the failure of his mRNA vaccine program.  In a recent interview Bourla confessed that the first two doses of spike protein mRNA only offer “limited protection” against covid-19. He even cast doubt on the “booster” shot, claiming it offers “reasonable protection” against hospitalization and death but “less protection” against infection. Bourla said a fourth shot should be available by March of 2022, and it should offer the greatest protection yet!  At this point Bourla is only spewing gobbledygook – complete and utter nonsense…. On April 1, 2021, Bourla said:  “The data also showed the vaccine was 100% effective against severe #COVID19 as defined by @CDCgov and 95.3% effective against severe COVID-19 as defined by @US_FDA.  Very reassuring news.” Now, in 2022, Bourla is essentially saying the same thing – that a fourth dose will be 100 percent effective against severe COVID-19.  https://www.naturalnews.com/2022-01-13-pfizer-ceo-admitted-shots-are-useless-double-jabbed-have-limited-protection-if-